問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
周政緯
下載
2023-05-01 - 2034-07-31
Condition/Disease
Test Drug
Participate Sites10Sites
Recruiting10Sites
2025-10-01 - 2027-09-30
Participate Sites3Sites
Recruiting3Sites
2024-03-01 - 2028-10-10
Participate Sites7Sites
Not yet recruiting4Sites
Recruiting2Sites
2024-12-02 - 2027-12-31
Participate Sites4Sites
Recruiting4Sites
2022-09-01 - 2026-12-31
Recruiting7Sites
2024-03-01 - 2030-07-16
2024-06-30 - 2029-06-30
Participate Sites8Sites
Recruiting8Sites
2023-04-01 - 2030-12-31
Breast Cancer
GDC-0077(Inavolisib)Alpelisib(Piqray)Fulvestrant (Faslodex)
Participate Sites6Sites
Not yet recruiting1Sites
Recruiting5Sites
2021-05-20 - 2023-05-15
Recruiting6Sites
全部
